OOIR: Observatory of International Research

Papers

(The median citation count of Journal of Health Politics Policy and Law is 2. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)

Article	Citations
Pandemic Politics: Timing State-Level Social Distancing Responses to COVID-19	203
The Emergence of COVID-19 in the US: A Public Health and Political Communication Crisis	172
Democracy, Capacity, and Coercion in Pandemic Response: COVID-19 in Comparative Political Perspective	98
Racism and the Political Economy of COVID-19: Will We Continue to Resurrect the Past?	81
Equitable Pandemic Preparedness and Rapid Response: Lessons from COVID-19 for Pandemic Health Equity	48
No Equity without Data Equity: Data Reporting Gaps for Native Hawaiians and Pacific Islanders as Structural Racism	37
Health Equity, Social Policy, and Promoting Recovery from COVID-19	30
Federalism Complicates the Response to the COVID-19 Health and Economic Crisis: What Can Be Done?	29
Lingering Legacies: Public Attitudes about Medicaid Beneficiaries and Work Requirements	27
Affordable but Inaccessible? Contraception Deserts in the US States	24
Fighting for America's Paradise: The Struggle against Structural Racism	15
The Treatment of Disability under Crisis Standards of Care: An Empirical and Normative Analysis of Change over Time during COVID-19	14
The Potential and Realized Impact of the Affordable Care Act on Health Equity	13
Coping with Denialism: How Street-Level Bureaucrats Adapted and Responded to COVID-19 in Tanzania	12
Who Stays at Home? The Politics of Social Distancing in Brazil, Mexico, and the United States during the COVID-19 Pandemic	12
Extending Postpartum Medicaid: State and Federal Policy Options during and after COVID-19	12
Who Counts Where? COVID-19 Surveillance in Federal Countries	11
What Is EU Public Health and Why? Explaining the Scope and Organization of Public Health in the European Union	11
Understanding the Anemic Global Response to COVID-19	11
Pursuing Pharmacoequity: Determinants, Drivers, and Pathways to Progress	10
Ideological Sorting of Physicians in Both Geography and the Workplace	10
Compounding Racialized Vulnerability: COVID-19 in Prisons, Jails, and Migrant Detention Centers	10
State Policies and Health Disparities between Transgender and Cisgender Adults: Considerations and Challenges Using Population-Based Survey Data	8
Factors Affecting State-Level Enforcement of the Federal Mental Health Parity and Addiction Equity Act: A Cross-Case Analysis of Four States	8
The No Surprises Act: A Bipartisan Achievement to Protect Consumers from Unexpected Medical Bills	8

The Political Economy of Market Power in Pharmaceuticals	8
Unsanitized and Unfair: How COVID-19 Bailout Funds Refuel Inequity in the US Health Care System	8
The Line between Medicaid and Marketplace: Coverage Effects from Wisconsin's Partial Expansion	8
The Affordable Care Act's Missing Consensus: Values, Attitudes, and Experiences Associated with Competing Health Reform Preferences	7
Going the Extra Mile? How Provider Network Design Increases Consumer Travel Distance, Particularly for Rural Consumers	7
Introduction to “COVID-19: Politics, Inequalities, and Pandemic”	7
Hydroxychloroquine for COVID-19: Variation in Regional Political Preferences Predicted New Prescriptions after President Trump's Endorsement	7
A Look Under the Hood: Regulatory Policy Making and the Affordable Care Act	7
Improving Access to High-Value, High-Cost Medicines: The Use of Subscription Models to Treat Hepatitis C Using Direct-Acting Antivirals in the United States	6
Inside ILSI: How Coca-Cola, Working through Its Scientific Nonprofit, Created a Global Science of Exercise for Obesity and Got It Embedded in Chinese Policy (1995–2015)	6
The Future of State All-Payer Claims Databases	6
The Political Realignment of Health: How Partisan Power Shaped Infant Health in the United States, 1915–2017	6
Marketing Opioids to Veterans and Older Adults: A Content Analysis of Internal Industry Documents Released from State of Oklahoma v. Purdue Pharma LP, et al.	6
Technically Accessible, Practically Ineligible: The Effects of Medicaid Expansion Implementation on Chronic Homelessness	6
Ten Years of Messaging about the Affordable Care Act in Advertising and News Media: Lessons for Policy and Politics	6
When Doctors strike: Making Sense of Professional Organizing in Kenya	6
Disaster Preparedness and Social Justice in a Public Health Emergency	6
Authoritarian Regime Legitimacy and Health Care Provision: Survey Evidence from Contemporary China	5
A Draconian Law: Examining the Navigation of Coalition Politics and Policy Reform by Health Provider Associations in Karnataka, India	5
Regional International Organizations and Health: A Framework for Analysis	5
State Policy and Mental Health Outcomes under COVID-19	5
Networked Health Care Governance in the European Union	5
Termites of Solidarity in the House of Austerity: Undermining Fiscal Governance in the European Union	5
Physician Trust in the News Media and Attitudes toward COVID-19	5
Policy Responses to the Addiction Crisis	5
Negotiating Change: Ideas, Institutions, and Political Actors in Tobacco Control Policy Making in Mauritius	5
Potemkin Protections: Assessing Provider Directory Accuracy and Timely Access for Four Specialties in California	5
Racism, Health, and Politics: Advancing Interdisciplinary Knowledge	5
Prescription Drug Priorities under the Biden Administration	5
Americans' View of the Impact of COVID-19: Perspectives on Racial Impacts and Equity	5
County-Level Segregation and Racial Disparities in COVID-19 Outcomes	4
More Than Words? How Highlighting Target Populations Affects Public Opinion about the Medicaid Program	4
What Is a “Racial Health Disparity”? Five Analytic Traditions	4
Introduction to “Subnational COVID-19 Politics and Policy”	4
Health Technology Assessment and Health Care Reimbursement in the European Union: Permissive Dissensus and the Limits of Harmonization through the Backdoor	4
A Mixed-Methods Approach to Understanding the Disconnection between Perceptions of Abortion Acceptability and Support for Roe v. Wade among US Adults	4
The Conditional Effects of Health on Voter Turnout	4
How Do Medicaid Agencies Improve Substance Use Treatment Benefits? Lessons from Three States' 1115 Waiver Experiences	4
Industry Payments to Physicians Are Kickbacks. How Should Stakeholders Respond?	4
Health “Brexternalities”: The Brexit Effect on Health and Health Care outside the United Kingdom	4
Entrenching Inequity, Eroding Democracy: State Preemption of Local Housing Policy	4
Value-Based Insurance Design: Clinically Nuanced Consumer Cost Sharing to Increase the Use of High-Value Medications	4
Prospects for Enforcing Prohibitions on Off-Label Drug Promotion after United States v. Caronia: An Analysis of Litigated Cases	3
Health Care and the Fate of Social Europe	3
The Rhetorical Transformations and Policy Failures of Prescription Drug Pricing Reform under the Trump Administration	3
Trajectories of Professional Authority: A Comparative Study of Medical Associations and Professional Authority Claims	3
The Contribution of Price Growth to Pharmaceutical Revenue Growth in the United States: Evidence from Medicines Sold in Retail Pharmacies	3
Self-Sourced Medication Abortion, Physician Authority, and the Contradictions of Abortion Care	3
Trends in the Quality of Evidence Supporting FDA Drug Approvals: Results from a Literature Review	3
History and Politics of Medication Abortion in the United States and the Rise of Telemedicine and Self-Managed Abortion	3

International Reference Pricing in the Context of US Drug Policy	3
How Workers Fared under the ACA	3
Mexican-Origin Women's Construction and Navigation of Racialized Identities: Implications for Health Amid Restrictive Immigrant Policies	3
Medicaid and Accelerated Approval: Spending on Drugs with and without Proven Clinical Benefits	3
Introduction to “Recontextualizing Physician Associations: Revisiting Context, Scope, Methodology”	3
The Bayh-Dole Act at 40: Accomplishments, Challenges, and Possible Reforms	3
Reduction in Medicaid Rebates Paid by Pharmaceutical Manufacturers for Outpatient Infused, Injected, Implanted, Inhaled, or Instilled Drugs: The 5i Loophole	3
Intellectual Property and the Politics of Public Good during COVID-19: Framing Law, Institutions, and Ideas during TRIPS Waiver Negotiations at the WTO	2
Undue Burdens: State Abortion Laws in the United States, 1994–2022	2
Health Insurance Loss during COVID-19 May Increase Support for Universal Health Coverage	2
Medicare's Stewardship Role to Improve Care Delivery: Opportunities for the Biden Administration	2
Activism for Abortion Rights and Access Is Global: What the United States Can Learn from the Rest of the World	2
Centralization vs. Decentralization in COVID-19 Responses: Lessons from China	2
State Regulation and Hospital Community Benefit Spending in Medicaid Expansion States	2
An Economic Perspective on the Affordable Care Act: Expectations and Reality	2
Diminishing Democracy in Health Policy: Partisanship, the Courts, and the End of Health Politics as We Knew It	2
Assessing US Pharmaceutical Policy and Pricing Reform Legislation in Light of European Price and Cost Control Strategies	2
Levels of Employment and Community Engagement among Low-Income Adults: Implications for Medicaid Work Requirements	2
Introduction: The Politics of Abortion 50 Years afterRoe	2
Medicare for All—Running Down a Dream	2
A Decade of ACOs in Medicare: Have They Delivered on Their Promise?	2
Comparatively Ineffective? PCORI and the Uphill Battle to Make Evidence Count in US Medicine	2
Why Did the ACA Co-Op Program Fail? Lessons for the Health Reform Debate	2
What Doctors Want: A Comment on the Financial Preferences of Organized Medicine	2
Pursuing Medicaid Block Grants with the Healthy Adult Opportunity Initiative: Dressing Up Old Ideas in New Clothes	2
How the Trump Administration's Pandemic Health Care Response Failed Racial Health Equity: Case Studies of Structural Racism and a Call for Equity Mindfulness in Federal Health Policy Making	2